Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia

Joen-Rong Sheu, Wei C. Hung, Ching-Hsiang Wu, Ming Chieh Ma, Ya Chen Kan, Chien-Huang Lin, Ming Shyan Lin, Hsiung N. Luk, Mao Hsiung Yen

研究成果: 雜誌貢獻文章同行評審

85 引文 斯高帕斯(Scopus)


Background - Thrombocytopenia frequently occurs early in the course of Gram-negative bacterial infections. Triflavin, an Arg-Gly-Asp-containing disintegrin, has been suggested to interfere with the interaction of fibrinogen with the glycoprotein IIb/IIIa complex. The present study was undertaken to determine whether triflavin could prevent thrombocytopenia in lipopolysaccharide (LPS)-treated rats. Methods and Results - In this study, 51Cr-labeled platelets were used to assess blood and tissue platelet accumulation after LPS challenge. The administration of LPS (4 mg/kg IV bolus) for 4 hours induced a reduction in radiolabeled platelets in blood and an obvious accumulation of platelets in liver. Triflavin (500 μg/kg) but not GRGDS (20 mg/kg) significantly prevented the alteration of radiolabeled platelet distribution in blood and liver when induced by LPS. Furthermore, triflavin but not GRGDS markedly suppressed the elevation in plasma thromboxane B2 concentration within the 4-hour period of LPS administration. In LPS-treated rats, the 5-hydroxytryptamine level was lower in the blood and higher in the liver compared with levels in normal saline-treated rats. Pretreatment with triflavin (500 μg/kg) significantly reversed the 5- hydroxytryptamine concentration in blood and liver of LPS-treated rats. In histological examinations and platelet adhesion assay, triflavin markedly inhibited the adhesion of platelets to subendothelial matrixes in vivo and in vitro. Conclusions - The results indicate that triflavin effectively prevents thrombocytopenia, possibly through the following 2 mechanisms: (1) Triflavin markedly inhibits platelet aggregation, resulting in decreased thromboxane A2 formation. (2) It inhibits the adhesion of platelets to subendothelial matrixes, thereby leading to a reversal in the distribution of platelets in blood and liver in LPS-treated rats.
頁(從 - 到)3056-3062
出版狀態已發佈 - 6月 15 1999

ASJC Scopus subject areas

  • 生理學
  • 心臟病學與心血管醫學


深入研究「Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia」主題。共同形成了獨特的指紋。